Berberine prevents progression from hepatic steatosis to steatohepatitis and fibrosis by reducing endoplasmic reticulum stress

The histological spectrum of nonalcoholic fatty liver diseases (NAFLD) ranges from hepatic steatosis to steatohepatitis and fibrosis. Berberine (BBR) is known for its therapeutic effect on obesity, hyperglycaemia and dyslipidaemia; however, its effect on NAFLD has yet to be thoroughly explored. Db/d...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Sci Rep
Päätekijät: Zhang, Zhiguo, Li, Bo, Meng, Xiangjian, Yao, Shuangshuang, Jin, Lina, Yang, Jian, Wang, Jiqiu, Zhang, Huizhi, Zhang, Zhijian, Cai, Dongsheng, Zhang, Yifei, Ning, Guang
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2016
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4746620/
https://ncbi.nlm.nih.gov/pubmed/26857750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep20848
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia